- cross-posted to:
- [email protected]
- cross-posted to:
- [email protected]
Summary
Over 250 branded drugs in the U.S. will see price increases starting Jan. 1, 2025, with most hikes below 10% and a median increase of 4.5%.
Key companies like Pfizer, Bristol Myers Squibb, and Sanofi are raising prices on treatments for COVID-19, cancer, and vaccines, citing R&D costs and inflation.
Some prices, such as Merck’s diabetes drugs, will be reduced.
Critics highlight that U.S. drug prices remain the highest globally, while manufacturers face pressure to moderate year-over-year price hikes.
Lol, what R&D Costs for already developed drugs?
Guess who footed the bill for all that emergency Covid R&D a few years ago? Hint - it was not the pharmaceutical companies.
US Tax Dollars Funded Every New Pharmaceutical in the Last Decade
We fund the medicine with our taxes, we pay for the medicine with our income, we take the medicine on our time. And we get nothing but a bill and maybe the drug working, if it doesn’t ensure a new addiction racket.
They didn’t even funded it without COVID, that drug was developed at a University IIRC
Well, the argument is that they need to cover new R&D costs
Know what industry has higher R&D costs than pharmaceuticals? Chips.
And my computers aren’t going up that much